Twitter | Pretraživanje | |
Pretraživanje Osvježi
SIRION Biotech GmbH 4 h
We are just 3 days away from the Emerging Cellular Therapies: Cancer and Beyond and Engineering the Genome joint meetings in Banff, Canada! Are you attending? Be sure to set up a meeting with us to learn about our viral vector technologies.
Reply Retweet Označi sa "sviđa mi se"
Varro Analytics 5 h
Odgovor korisniku/ci @Varro_Analytics
4). IPO is of course now scheduled for tomorrow (Feb 6) Here is the roadshow video:
Reply Retweet Označi sa "sviđa mi se"
Twist Bioscience 6 h
Reply Retweet Označi sa "sviđa mi se"
ASGCT 6 h
Did you know there are more than 400 active and recruiting clinical trials in and across the U.S.? You can search them using our Clinical Trials Finder, which is updated daily.
Reply Retweet Označi sa "sviđa mi se"
Advarra 8 h
The FDA released final guidance on developing human products- for adult and pediatric patients with retinal disorders. Read more:
Reply Retweet Označi sa "sviđa mi se"
AVROBIO 9 h
AVROBIO is growing! Join us as we strive to take mainstream for people with genetic disease - see opportunities here:
Reply Retweet Označi sa "sviđa mi se"
Francisco López Jaime 11 h
Reply Retweet Označi sa "sviđa mi se"
CRISPR Medicine 11 h
'Roundup' soldiers in the future. US Army researchers develop in mice that could give soldiers long-lasting protection against lethal nerve agents.
Reply Retweet Označi sa "sviđa mi se"
Specialty Pharmacy Continuum 13 h
Interim data from an ongoing of an investigational for has shown that a single administration of the treatment resulted in a complete cessation of bleeds up to the 26-week interim end point.
Reply Retweet Označi sa "sviđa mi se"
Single Use Support 15 h
4 hacks that allow you to push patient safety during cell and gene therapies to the next level. Check out our – our logistical solution for a successful CAR-T cell therapy!  _________
Reply Retweet Označi sa "sviđa mi se"
flosz 15 h
Reply Retweet Označi sa "sviđa mi se"
Simon Fletcher 18 h
Prof Pasi states the importance of discussing minimum factor expression expectations rather than means or medians in
Reply Retweet Označi sa "sviđa mi se"
Simon Fletcher 18 h
Odgovor korisniku/ci @abookclubof1
An interestingly a majority of the audience accept that an expressional lifespan of 10-15 years would be acceptable. Need to know whether that would be as acceptable to those recieveing the therapy.
Reply Retweet Označi sa "sviđa mi se"
eXmoor Pharma 19 h
A new report explores viral vectors, considered to be the linchpin of . Read the full article here:
Reply Retweet Označi sa "sviđa mi se"
RoslinCT 19 h
[Infographic] We can’t believe that the first month of 2020 is already over! Reflecting back, 2019 was a great year for RoslinCT. Looking ahead, 2020 is already gearing up to be even better!
Reply Retweet Označi sa "sviđa mi se"
CaltagMedsystemsLtd 20 h
We're here at Booth 22 at Cell and Gene Therapy Innovation Summit in Berlin - come and say hello!
Reply Retweet Označi sa "sviđa mi se"
Maurice 4. velj
Nice slide on capacity vs potential demand in NIH talk
Reply Retweet Označi sa "sviđa mi se"
Leah Kesselman, CellCAN 4. velj
These talks have been broken up into bite-sized pieces - if you have 15-30 minutes, you can watch one of these webinars from our wonderful supply chain and logistics speakers!
Reply Retweet Označi sa "sviđa mi se"
pharmanewsintel 3. velj
With more than 900 investigational new drug applications for gene therapies currently in development, a new deluge of FDA final and draft guidances aim to accelerate development in the field of
Reply Retweet Označi sa "sviđa mi se"
Patient Worthy 31. sij
Will Therapies for Neurological Disorders Bring Forth a New Era for Biotech?
Reply Retweet Označi sa "sviđa mi se"